Company Filing History:
Years Active: 2024
Title: The Innovations of Jinqiang Zhang
Introduction
Jinqiang Zhang is a notable inventor based in Chongqing, China. He has made significant contributions to the field of cyclic peptides, particularly in the development of novel analogs that have potential therapeutic applications.
Latest Patents
Jinqiang Zhang holds a patent for cyclic peptides and their uses, specifically focusing on novel cyclic peptide GHRP-6 analogs. These analogs are described by the formula (I) or pharmaceutically acceptable esters or salts thereof. The cyclic peptide GHRP-6 analogs may be utilized for modulating CD36 activity, which is crucial for treating CD36-related diseases, disorders, or conditions in subjects, such as atherosclerosis and age-related macular degeneration.
Career Highlights
Jinqiang Zhang is affiliated with the Université de Montréal, where he continues to advance his research in the field of cyclic peptides. His work has garnered attention for its potential impact on medical treatments and therapies.
Collaborations
Some of his notable coworkers include William D. Lubell and Huy Ong, who have collaborated with him on various research projects.
Conclusion
Jinqiang Zhang's innovative work in cyclic peptides exemplifies the potential of scientific research to address significant health issues. His contributions are paving the way for new therapeutic options in the treatment of various diseases.